Literature DB >> 16618746

Transformation of late passage insulin-like growth factor-I receptor null mouse embryo fibroblasts by SV40 T antigen.

Susan L Spence1, Arthur L Shaffer, Louis M Staudt, Sewit Amde, Sutana Manney, Cheryl Terry, Keith Weisz, Peter Nissley.   

Abstract

There is evidence that the insulin-like growth factor-I (IGF-I) receptor is required for transformation by a variety of viral and cellular oncogenes in a mouse embryo fibroblast model. To further investigate the IGF-I receptor signaling pathways that are required for the permissive effect of the receptor on transformation by SV40 T antigen, we established three independent fibroblast cell lines each from wild-type and IGF-I receptor null embryos (R-). We transfected the wild-type and R- cell lines with an SV40 T antigen plasmid and selected three clones from each cell line that expressed T antigen. As in previous reports, none of the cloned R- cell lines expressing T antigen were transformed as measured by the ability to form large colonies in soft agar. However, with further passage, all three T antigen-expressing clones from one of the R- cell lines (R(-)3) formed large colonies in soft agar and the transformation of these T antigen-expressing clones was confirmed by tumorigenesis experiments in immunodeficient mice. DNA microarray analysis comparing gene expression between early passage and late passage R(-)3/T antigen clones showed, among other changes, an increase in the expression of ErbB-3 mRNA in the late passage clones. Also, the expression of ErbB-3 protein was dramatically increased in the late passage R(-)3/T antigen clones. We conclude that late passage IGF-I receptor null mouse embryo fibroblasts can be transformed by SV40 T antigen, and that ErbB-3 may play a role in permitting transformation by T antigen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618746     DOI: 10.1158/0008-5472.CAN-05-2257

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Insulin-like growth factor 2 and the insulin receptor, but not insulin, regulate fetal hepatic glycogen synthesis.

Authors:  Li Liang; Wei Hui Guo; Diego R Esquiliano; Masato Asai; Susana Rodriguez; Jodel Giraud; Jake A Kushner; Morris F White; Mary Frances Lopez
Journal:  Endocrinology       Date:  2009-12-23       Impact factor: 4.736

2.  IGF-IR-dependent expression of Survivin is required for T-antigen-mediated protection from apoptosis and proliferation of neural progenitors.

Authors:  E Gualco; K Urbanska; G Perez-Liz; T Sweet; F Peruzzi; K Reiss; L Del Valle
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.